Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Genet Med
; 21(2): 512-515, 2019 02.
Article
in En
| MEDLINE
| ID: mdl-30190610
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Risk_factors_studies
Language:
En
Journal:
Genet Med
Journal subject:
GENETICA MEDICA
Year:
2019
Type:
Article
Affiliation country:
Japan